BioSpace News Archive

Business

Vividion and Roche Partner on Research Pact Worth “Several Billion Dollars”

The companies will leverage Vividion’s proteomics screening platform and small molecule library to target novel E3 ligases in addition to a variety of oncology and immunology therapy targets.

May 19, 2020
·
3 min read
·
Mark Terry
Business

U.S. Government and Phlow Corp. Partner to Build Stockpile of APIs and Other Key Drug Ingredients

As part of the agreement, Phlow will help build the United States’ first Strategic Active Pharmaceutical Ingredients Reserve, a long-term, national stockpile to secure key ingredients used to manufacture the most essential medicines in the United States.

May 19, 2020
·
3 min read
·
Alex Keown
BioCapital

Rallybio Plans Phase I/II Trial for Lead Asset Following $145 Million Series B

Additionally, the funds will drive the development of other assets in the company’s portfolio, including RLYB212, which is in preclinical development to address a rare hematologic disease, and three preclinical protein therapeutics for the treatment of rare immuno-inflammatory diseases.

May 19, 2020
·
2 min read
·
Alex Keown
FDA

FDA Grants Genentech’s Checkpoint Inhibitor Tecentriq Another NSCLC Approval

The approval was based on interim analysis from the company’s Phase III IMpower110 trial.

May 19, 2020
·
2 min read
·
Mark Terry
Business

Aetion and FDA Team Up for RWE Study to Advance Understanding of COVID-19

Research conducted under the collaboration will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns through the use of relevant and new data sources.

May 19, 2020
·
3 min read
·
Alex Keown
Business

Immunai Founders Discuss Plan to Map the Entire Immune System

With its proprietary, top-down view of the immune system and purportedly the world’s largest proprietary data devoted to clinical immunologics, it aims to catalyze significant improvements in disease detection, diagnosis and treatment.

May 19, 2020
·
4 min read
·
Gail Dutton
Policy

Biopharma Update on the Novel Coronavirus: May 19

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 19, 2020.

May 19, 2020
·
4 min read
·
BioSpace Editorial Staff
Biotech Beach

Amplyx Closes Oversubscribed $90 Million Series C to Advance Pipeline

San Diego-based Amplyx Pharmaceuticals closed a Series C extension round worth $53 million, bringing the Series C round total to more than $90 million.

May 19, 2020
·
2 min read
·
Mark Terry
Business

CDC to Launch Massive Population-based Antibody Testing for SARS-CoV-2

Expected to launch in June or July, the study plans to test as many as 325,000 people to learn how the SARS-CoV-2 virus is spreading nationally, according to Reuters, reporting before the official announcement.

May 19, 2020
·
4 min read
·
Gail Dutton
Business

BerGenBio ASA: Results for the First Quarter 2020

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for unmet medical need, announces its results for the first quarter 2020.

May 19, 2020
·
6 min read